Epitope domain and plasminogen activating site (s) in streptokinase molecule
链激酶分子中的表位结构域和纤溶酶原激活位点
基本信息
- 批准号:05670268
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have previously reported that a monoclonal antibody (mAb), N-59, prepared against streptokinase (SKase) from a group A,M type 12 streptococcal isolate (strain A374) from a patient with poststreptococcal glomerulonephritis (PSGN) recognized an epitope also present in SKase from a group C Streptococcus (strain H46A) which is not a PSGN isolate.However, another mAb, RU-1, prepared against SKase (nephritis strain-assiciated SKase, NSA-SKase) from strain A374 reacted only with the homologous SKase and not with common-SKase (C-SKase) from strain H46A.In addition, the complete amino acid sequence of the NSA-SKase of strain A374 was determined, and the epitope domain specific for RU-1 mAb reacted only with the NSA-SKase was localized to residues 164-236.Both pin technology and ELISA test were used to the determination of epitope domain involved in the internal region of NSA-SKase molecule reacted with RU-1 mAb. As the results, RU-1 mAb reacted with residues 177-185 (PSLKERYHL), and the minimum epitope domain, which reacts with RU-1 mAb, was residues 177-180 (PSLK).The other side, N-59 mAb reacted with almost all of SKase (C-SKase). The epitope domain of C-SKase reacted with N-59 mAb was analyzed. As the results, N-59 mAb recognized residues 324-332 (RDLYDPRDK) in C-SKase molecule, and the minimum epitope domain was residues 324-331 (RDLYDPRD).
我们曾报道过一株来自A、M-12型链球菌分离株(A374株)的抗链球菌酶(Skase)的单抗N-59,该单抗可识别非PSGN分离株的C群链球菌(H46A株)的Skase表位。而从A374株制备的抗Skase(肾炎株相关的Skase,NSA-Skase)的单抗RU-1仅与同源Skase反应,而不与H46A株的普通Skase(C-Skase)反应测定了A374株NSA-Skase的全长氨基酸序列,并将RU-1mAb仅与NSA-Skase反应的表位结构域定位在164-236位。结果表明,RU-1单抗与177-185位残基(PSLKERYHL)反应,最小表位区域为177-180位(PSLK),N-59位单抗与Skase几乎全部反应(C-Skase)。分析了C-Skase与N-59单抗反应的表位结构域。结果表明,N-59mAb识别C-Skase分子中残基324-332(RDLYDPRDK),最小表位区域为残基324-331(RDLYDPRD)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHKUNI Hisashi其他文献
OHKUNI Hisashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHKUNI Hisashi', 18)}}的其他基金
Effects of the extracellular products from Streptococcus mitis and the heat killed-whole cells to vascular endotherial cells and monocyte-derived macrophages
轻链球菌胞外产物和热灭活全细胞对血管内皮细胞和单核细胞源性巨噬细胞的影响
- 批准号:
10670273 - 财政年份:1998
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Plasma component inhibits platelet aggregation caused by the extracellulal products of Streptococus mitis
血浆成分抑制轻链球菌细胞外产物引起的血小板聚集
- 批准号:
08670322 - 财政年份:1996
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
- 批准号:82372014
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
高致病性2型猪链球菌Sao-M蛋白Epitope-focused新型疫苗的研究
- 批准号:81701635
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
自身免疫性T细胞的抗原决定簇在抗肾小球基底膜病发病中的启动机制
- 批准号:81170645
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
包斑蛋白与周斑蛋白抗原表位分析及其在副肿瘤性天疱疮发病中的作用
- 批准号:81130030
- 批准年份:2011
- 资助金额:260.0 万元
- 项目类别:重点项目
改良HCV多表位基因疫苗及磁性微粒的应用基础研究
- 批准号:30901270
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
胰腺癌MUC4抗原多表位嵌合DNA疫苗的设计和免疫研究
- 批准号:30500492
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence
B 细胞受体序列抗原特异性高通量作图技术
- 批准号:
10734412 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis
囊泡表位转录本测序 (VET-seq):用于单囊泡分析的基于液滴的多组学分析平台
- 批准号:
10613257 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Epitope-Based CSP Vaccines Optimized to Achieve Long-Term Sterile Immunity
经过优化的基于表位的 CSP 疫苗可实现长期无菌免疫
- 批准号:
10637778 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Non-canonical epitope presentation and antigen processing by MHC-E
MHC-E 的非典型表位呈递和抗原加工
- 批准号:
10801509 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
B 细胞表位发现和抗体保护机制:对登革热 4、Powassan、基孔肯雅热和委内瑞拉马脑炎病毒的反应
- 批准号:
10909763 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Development of disease-specific TCR epitope analysis based on ribosome display
基于核糖体展示的疾病特异性 TCR 表位分析的发展
- 批准号:
23K19358 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
项目2:雄激素剥夺作为免疫调节疗法与前列腺癌靶向免疫疗法相结合
- 批准号:
10555401 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Investigating Immunogenicity of Mpox and Mpox vaccine Imvamune in people living with HIV
研究 Mpox 和 Mpox 疫苗 Imvamune 对 HIV 感染者的免疫原性
- 批准号:
481131 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Operating Grants